Cipla enters into a licensing agreement with Gilead to expand access to Covid-19 treatment

This article was originally published here

This agreement is part of Cipla’s efforts to enhance global access to life-saving treatments for patients affected by the pandemic. As part of the agreement, Cipla will be

The post Cipla enters into a licensing agreement with Gilead to expand access to Covid-19 treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply